125 related articles for article (PubMed ID: 29995202)
21. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
[TBL] [Abstract][Full Text] [Related]
22. My encounters with Krabbe disease: A personal recollection of a 40-Year journey with young colleagues.
Suzuki K
J Neurosci Res; 2016 Nov; 94(11):965-72. PubMed ID: 27638581
[TBL] [Abstract][Full Text] [Related]
23. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor.
Matsuda J; Vanier MT; Saito Y; Suzuki K; Suzuki K
Hum Mol Genet; 2001 Nov; 10(23):2709-15. PubMed ID: 11726558
[TBL] [Abstract][Full Text] [Related]
24. Acute Gaucher Disease-Like Condition in an Indian Infant with a Novel Biallelic Mutation in the Prosaposin Gene.
Radha Rama Devi A; Kadali S; Radhika A; Singh V; Kumar MA; Reddy GM; Naushad SM
J Pediatr Genet; 2019 Jun; 8(2):81-85. PubMed ID: 31061751
[TBL] [Abstract][Full Text] [Related]
25. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs.
Zhao Q; Hay N; Morales CR
Mol Reprod Dev; 1997 Sep; 48(1):1-8. PubMed ID: 9266755
[TBL] [Abstract][Full Text] [Related]
26. Non-neuronopathic Gaucher disease due to saposin C deficiency.
Tylki-Szymańska A; Czartoryska B; Vanier MT; Poorthuis BJ; Groener JA; Ługowska A; Millat G; Vaccaro AM; Jurkiewicz E
Clin Genet; 2007 Dec; 72(6):538-42. PubMed ID: 17919309
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
[TBL] [Abstract][Full Text] [Related]
28. A rare form of Gaucher disease resulting from saposin C deficiency.
Kang L; Zhan X; Ye J; Han L; Qiu W; Gu X; Zhang H
Blood Cells Mol Dis; 2018 Feb; 68():60-65. PubMed ID: 28457694
[TBL] [Abstract][Full Text] [Related]
29. The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C.
Zhou X; Sullivan PM; Sun L; Hu F
J Neurochem; 2017 Oct; 143(2):236-243. PubMed ID: 28640985
[TBL] [Abstract][Full Text] [Related]
30. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
31. Globoid cell leukodystrophy (Krabbe's disease): update.
Suzuki K
J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
33. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
[TBL] [Abstract][Full Text] [Related]
34. Clinical, biochemical and molecular characterization of prosaposin deficiency.
Motta M; Tatti M; Furlan F; Celato A; Di Fruscio G; Polo G; Manara R; Nigro V; Tartaglia M; Burlina A; Salvioli R
Clin Genet; 2016 Sep; 90(3):220-9. PubMed ID: 26831127
[TBL] [Abstract][Full Text] [Related]
35. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
[TBL] [Abstract][Full Text] [Related]
36. [From gene to disease; Krabbe disease and galactosylceramidase deficiency].
Kleijer WJ; van Diggelen OP; Halley DJ; van der Ploeg AT; Mancini GM
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):826-8. PubMed ID: 15141649
[TBL] [Abstract][Full Text] [Related]
37. Characterization of
Sellin J; Schulze H; Paradis M; Gosejacob D; Papan C; Shevchenko A; Psathaki OE; Paululat A; Thielisch M; Sandhoff K; Hoch M
Dis Model Mech; 2017 Jun; 10(6):737-750. PubMed ID: 28389479
[TBL] [Abstract][Full Text] [Related]
38. Saposin B-Deficient Metachromatic Leukodystrophy Mimicking Acute Flaccid Paralysis.
Madaan P; Jauhari P; Chakrabarty B; Kumar A; Gulati S
Neuropediatrics; 2019 Oct; 50(5):318-321. PubMed ID: 31319425
[TBL] [Abstract][Full Text] [Related]
39. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
40. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease.
Marques AR; Willems LI; Herrera Moro D; Florea BI; Scheij S; Ottenhoff R; van Roomen CP; Verhoek M; Nelson JK; Kallemeijn WW; Biela-Banas A; Martin OR; Cachón-González MB; Kim NN; Cox TM; Boot RG; Overkleeft HS; Aerts JM
Chembiochem; 2017 Feb; 18(4):402-412. PubMed ID: 28000364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
